Drug Shortage Report for ZINECARD
Report ID | 185721 |
Drug Identification Number | 02153432 |
Brand name | ZINECARD |
Common or Proper name | ZINECARD |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | DEXRAZOXANE |
Strength(s) | 250MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 25mL vial |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-02-28 |
Estimated end date | |
Actual end date | 2023-10-04 |
Shortage status | Resolved |
Updated date | 2023-10-31 |
Company comments | |
Health Canada comments | De-escalation from Tier 3 stats October 26, 2023. |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-02-28 | English | Compare |
v2 | 2023-02-28 | French | Compare |
v3 | 2023-03-01 | English | Compare |
v4 | 2023-03-21 | English | Compare |
v5 | 2023-09-13 | English | Compare |
v6 | 2023-09-13 | French | Compare |
v7 | 2023-09-27 | English | Compare |
v8 | 2023-09-27 | English | Compare |
v9 | 2023-09-27 | French | Compare |
v10 | 2023-10-04 | English | Compare |
v11 | 2023-10-04 | French | Compare |
v12 | 2023-10-05 | English | Compare |
v13 | 2023-10-31 | English | Compare |
v14 | 2023-10-31 | English | Compare |
v15 | 2023-10-31 | French | Compare |
Showing 1 to 15 of 15